Diabetes Board decisions

The Veteran's service in Thailand during the Vietnam Era is presumed to have exposed him to herbicides, which allows for presumptive service connection of diabetes.

The Board has remanded the case due to incomplete medical opinions regarding whether the Veteran's obstructive sleep apnea is secondary to his service-connected diabetes mellitus and whether obesity, which may be aggravated by diabetes mellitus, contributed to his OSA.

The Veteran's bilateral hearing loss is currently rated as noncompensable, and the Board finds that a compensable rating is not warranted.,Service connection for diabetes mellitus type II cannot be established as secondary to in-service herbicide exposure due to insufficient evidence of such exposure.

The Veteran's diabetes mellitus, type II, is rated at a 40 percent since January 14, 2015. The rating is granted for this period.

The Board has remanded the claims for service connection for diabetes mellitus, type II, diabetic neuropathy of the four extremities, and erectile dysfunction due to potential exposure to herbicide agents during service. Further development is needed to determine if the Veteran was exposed to Agent Orange while serving aboard USS Ranger in the Gulf of Tonkin.

The Board has remanded the case due to insufficient compliance with previous remand directives regarding service connection for diabetes mellitus. The examiner is asked to address whether the Veteran's DM is related to in-service chemical exposure and whether it is aggravated by any acquired psychiatric disorder.

The Board denied service connection for diabetes mellitus type II, finding that the preponderance of evidence did not support a current diagnosis and noting that elevated blood sugar levels do not constitute a disability.

The Veteran's type II diabetes mellitus is presumed to be causally related to herbicide agent exposure during service. The bilateral upper and lower extremity peripheral neuropathy is found to be a complication of the service-connected type II diabetes mellitus.

The Veteran's claim for a rating in excess of 20 percent for diabetes mellitus, type II is denied. The Board finds that additional development of the evidence is required to determine whether service connection for bladder cancer is warranted.

The Board denied service connection for diabetes mellitus and peripheral neuropathy, finding no evidence of herbicide exposure in Vietnam or Thailand. The Veteran's claims were not legally possible due to lack of service-connected primary condition.

The Board denied the Veteran's claims for service connection for prediabetes, allergic rhinitis, helicobacter pylori, hypertension, osteoarthritis, a back disability (secondary to bilateral foot disability), and right and left knee disabilities. The effective dates were not addressed as they are not relevant to the disposition.

The Board denied a rating in excess of 20 percent for the appellant's service-connected diabetes mellitus, type II, finding that the evidence did not support a requirement for regulation of activities.

The Veteran's claim for an increased rating for diabetic retinopathy has been withdrawn by his attorney of record, and the appeal is dismissed.

The Veteran's claim for compensation under 38 U.S.C. § 1151 for diabetes mellitus is granted, and the claims for service connection for varicose veins, viral meningitis, right knee disability, bilateral flatfeet, shin splints (to include as due to bilateral flatfeet), and an acquired psychiatric disorder are denied.

The Veteran's service-connected disabilities did not prevent him from securing and following a substantially gainful occupation prior to June 12, 2017.

The Board has granted service connection for diabetes mellitus, type II, finding that the Veteran was exposed to herbicides during his deployment in Thailand and thus presumptively related to this exposure.

The Board has granted service connection for diabetes mellitus Type II on a presumptive basis due to in-service herbicide exposure during the Vietnam Era.

The Veteran's PTSD is rated at 70 percent, effective December 11, 2019. The appeal for higher ratings prior to this date was denied.

The Board has remanded several issues for further development and consideration, including obtaining additional medical records and readjudicating the service connection claims. The appeals are not about service connection via a presumption like PACT Act/Agent Orange/Camp Lejeune.

The Veteran's diabetes mellitus, type II, was not incurred as a result of active duty service and is not shown to be causally or etiologically related to an in-service event, injury, or disease.,The preponderance of the evidence shows that the Veteran’s peripheral neuropathy was not manifest during active service and is not shown to be causally or etiologically related to an in-service event, injury, or disease.,The preponderance of the evidence shows that the Veteran's erectile dysfunction was not manifest during active service and is not shown to be causally or etiologically related to an in-service event, injury, or disease.,The preponderance of the evidence shows that the Veteran’s eye disability was not manifest during active service and is not shown to be causally or etiologically related to an in-service event, injury, or disease.,The preponderance of the evidence shows that the Veteran's arthritis of the shoulders, back, hips and feet was not manifest during active service and is not shown to be causally or etiologically related to an in-service event, injury, or disease.,The preponderance of the evidence shows that the Veteran’s vertigo was not manifest during active service and is not shown to be causally or etiologically related to an in-service event, injury, or disease.,The preponderance of the evidence shows that the Veteran's pancreatic cancer was not manifest during active service and is not shown to be causally or etiologically related to an in-service event, injury, or disease.